Skip to content

Blog

Latest articles, insights, and updates from the blog.

191 articles

Have a question about this topic?

Use the contact page when you need to send feedback, request a correction, or ask about the resource.

News1 min read

Glutamate Treatments Reshape TRD Care in 2026

New research confirms glutamate-based treatments like esketamine offer fast relief for treatment-resistant depression. Here's what it means for online ketamine care.

News1 min read

New Research on Ketamine Side Effects and What It Means

New clinical data on NMDA antagonist side effects and discontinuation rates reveals what telehealth ketamine patients should expect from accountable providers.

News1 min read

AI Prescribing Psych Meds: What It Means for Ketamine Care

A Utah AI prescribing pilot raises safety questions. Here's what it means for ketamine telehealth patients seeking safe, supervised online treatment.

News1 min read

How Doctors Choose TRD Treatments in 2026

New guidance on TRD treatment selection highlights ketamine's role alongside esketamine and brain stimulation. What patients need to know before choosing care.

News1 min read

Esketamine's Role in Treatment-Resistant Depression Care

Comparing ketamine-based options for treatment-resistant depression in 2026: how esketamine differs from generic ketamine and what to ask before choosing.

News1 min read

New PTSD Prevention Drug Trial: What It Means for Patients

A new DoD-backed Phase 2a trial tests BXCL501 for acute stress reactions. Here's what it means for ketamine patients seeking PTSD treatment in 2026.

News1 min read

Why 'Good Enough' Depression Care Is No Longer Enough

New clinical guidance pushes for true remission in treatment-resistant depression. Here's what that means for patients exploring ketamine therapy.

News1 min read

BPL-003 Trial Results: What They Mean for TRD Patients

New phase 2a data on BPL-003 shows lasting depression symptom reduction. Here's what it means for patients exploring ketamine and emerging TRD therapies.

News1 min read

New PTSD Prevention Drug Trial: What Patients Should Know

A new DoD-backed trial is testing BXCL501 for acute stress reactions. Here's what it means for ketamine patients pursuing PTSD treatment today.

News1 min read

Beyond 'Less Bad': New Push for True TRD Remission

Psychiatrists are shifting TRD goals from symptom reduction to full remission. Here's what that means for patients and ketamine therapy in 2026.

How Telehealth Works1 min read

Video Visit Tips for Ketamine Patients: Making the Most of Your Telehealth Appointments

Practical tips for telehealth ketamine video visits. Learn how to prepare your space, optimize your technology, communicate effectively with your provider, and get the most from every session.

Cost Insurance1 min read

Tax Deductions for Ketamine Therapy: What You Can Claim

Can you deduct ketamine therapy on your taxes? Learn about medical expense deductions, IRS rules, what qualifies, documentation requirements, and strategies to maximize your tax benefit.